基金市场周报：医药生物板块表现较优，主动投资股票基金平均收益相对领先-20250526

Group 1: Market Overview - The report indicates that during the period from May 19 to May 23, 2025, the Shanghai Composite Index fell by 0.57% and the Shenzhen Component Index decreased by 0.46% [3] - Among the Shenwan first-level industries, the pharmaceutical and biological sector performed relatively well, while the overall market saw more declines than gains [3][9] - Various types of funds experienced increases, with actively managed equity funds rising by 0.42%, mixed funds by 0.08%, and bond funds by 0.08% [3] Group 2: Fund Performance - The report highlights that funds heavily invested in the pharmaceutical and biological sectors showed superior performance [14] - Notable actively managed equity funds included: - Anxin Medical Health Stock A with a return of 11.08% - Dongwu Medical Services Stock A with a return of 10.68% [15] - For the year-to-date, the top-performing funds included: - Ping An Advanced Manufacturing Theme Stock A with a return of 52.31% - Zhongyin Big Health Stock A with a return of 48.47% [15] Group 3: Bond Market Insights - In the bond market, the report notes that long-term pure bond funds led with a return of 0.08%, while short-term pure bond funds increased by 0.04% [17] - The average return for convertible bond funds was reported at 3.87% for the year [17] Group 4: QDII Fund Performance - The report states that alternative asset-gold QDII funds had a significant increase of 3.02% during the period, with a year-to-date return of 25.16% [19] - Other QDII fund categories showed varied performance, with the alternative asset-commodity QDII funds rising by 1.47% [19]